VALCYTE(R) Powder for Constitution

Similar documents
VALCYTE(R) F.C. Tablets (450 mg)

KLONOPIN(R) Tablets (2 mg)

PEGASYS(R) Vials (0.135 mg/ml)

ANAPROX(R) Tablets (550 mg)

CELLCEPT (R) Oral Suspension

- VALCYTE Powder for Oral Solution 50 mg/ml

Xenical(R) Capsules (120 mg)

ACTEMRA(R) Sterile Concentrate for Injection (80 mg)

ACTEMRA(R) Sterile Concentrate for Injection (400 mg)

XOFLUZATM (Baloxavir Marboxil) Tablets 20mg

ACTIVASE Vials (100 mg)

PEGASYS(R) Prefilled Syringe (180 mcg/0.5 ml)

TECENTRIQ Vials (1,200 mg/20 ml)

AVASTIN(R) Vials (400 mg)

XOLAIR(R) Vials (150 mg)

CATHFLO ACTIVASE(R) Vials (2 mg)

XOLAIR(R) PFS (150 mg)

TAMIFLU(R) Capsules (75 mg)

LUCENTIS(R) Vials (0.5 mg/0.05 ml)

GAZYVA(R) Vials (1,000 mg/40 ml)

VALCYTE Powder for Oral Solution

RITUXAN(R) Vials (100 mg/10 ml)

RITUXAN(R) Vials (100 mg/10 ml)

Bioland Scientific LLC

ANEXATE Ampoules 0.5 mg/5 ml

Version 1.7 Revision Date Print Date : CHEMTREC

KLONOPIN(R) Tablets (2.0 mg)

SAFETY DATA SHEET <#####> PERMECTRIN CDS POUR-ON INSECTICIDE Version 1.2 Revision Date 02/15/2013

HERCEPTIN HYLECTATM Vials (600 mg/5 ml) SC

RITUXAN HYCELATM Vials (1,400 mg/23,400 Units per 11.7 ml)

INVIRASE(R) Capsules (200 mg)

Citric acid anhydrous

Issue Date: 10-Jun-2015 Revision Date: 22-Jun-2015 Version 1 1. IDENTIFICATION 2. HAZARDS IDENTIFICATION

TAMIFLU(R) Capsules (75 mg)

Version 0.1 Revision Date 05/29/2015 Print Date 11/10/2015

CAS-No. EC-No. Index-No. Concentration Calcium diformate May be harmful if inhaled. Causes respiratory tract irritation.

HERCEPTIN(R) Vials (150 mg)

Material Safety Data Sheet

ESBRIET(R) Capsules (267 mg)

Material Safety Data Sheet

SAFETY DATA SHEET <#####> Marquis (Ponazuril) EPM Paste Version 2.0 Revision Date 07/31/2015

DILATREND Tablets 6.25 mg

Fluorescein, Disodium Salt

Material Safety Data Sheet

May be harmful if inhaled. Causes respiratory tract irritation. Skin. May be harmful if absorbed through skin. Causes skin irritation.

EARTH OPTIONS BY RAID - INSECTICIDAL SOAP

WINDEX ORIGINAL GLASS CLEANER WITH AMMONIA-D

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET

Material Safety Data Sheet

MATERIAL SAFETY DATA SHEET

1. IDENTIFICATION 2. HAZARDS IDENTIFICATION. Appearance Yellow liquid Physical State Liquid Odor Mild

Version 1.0 Revision Date 09/30/2016 Print Date 12/20/2016. : Honeywell International Inc. 115 Tabor Road Morris Plains, NJ

MetriCide Powder Activator Date Prepared: 11/1/2012

SIGMA-ALDRICH. Material Safety Data Sheet 1. PRODUCT AND COMPANY IDENTIFICATION. Product name : Gramicidin A from Bacillus brevis

CAS-No. EC-No. Index-No. Concentration Disodium 6-hydroxy-5-[(4-sulphonatophenyl)azo]naphthalene-2-sulphonate

ROACCUTANE Capsules 40 mg

Raid Bed Bug Detector & Trap

Interferon alfa-2a Solution

Issue Date: 20-Jun-2000 Revision Date: 08-Sep-2014 Version 1 1. IDENTIFICATION. Carpet and upholstery stain remover. 2. HAZARDS IDENTIFICATION

SCOTT Golden Lotion Soap

FFB 716. Version 21 Revision Date 2012/10/29 Print Date 2013/03/02

SAFETY DATA SHEET <#####> Baytril Otic Version 2.0 Revision Date 09/02/2015

Material Safety Data Sheet

SCOTT Continuous Air Freshener Refill - Natural

CELLCEPT(R) Powder for Oral Suspension

HELENA LABORATORIES 1530 Lindbergh Dr. / P.O. Box 752 Beaumont, TX USA Toll Free

LEXOTAN Tablets 3 mg

GLADE PLUG-INS SCENTED OIL - HAWAIIAN BREEZE

WINDEX ORIGINAL GLASS CLEANER

MATERIAL SAFETY DATA SHEET

COPEGUS(R) F.C. Tablets (200 mg)

SAFETY DATA SHEET. Emergency Overview Warning! Causes serious eye irritation. Irritating to respiratory system and skin.

GLADE PLUGINS SCENTED OIL (CLEAN LINEN )

Material Safety Data Sheet

MATERIAL SAFETY DATA SHEET

Revision Date 10/20/2017 SDS Number GEN_SOF Number : S.C. Johnson & Son, Inc Howe Street Racine WI

MATERIAL SAFETY DATA SHEET

Issue Date: 12-Nov-2014 Revision Date: 12-Nov-2014 Version 1 1. IDENTIFICATION. Glass Cleaner, Ammonia 2. HAZARDS IDENTIFICATION

WINDEX AUTO GLASS & interior

MATERIAL SAFETY DATA SHEET

SAFETY DATA SHEET VIVAK Copolyester. Plastic sheet products including signage, point of purchase displays, and photo frames.

MATERIAL SAFETY DATA SHEET

Distributed By Aetna Plastics Page 1 of 5 PLASKOLITE, INC. SAFETY DATA SHEET VIVAK Copolyester 1. IDENTIFICATION OF THE SUBSTANC

Material Safety Data Sheet

MATERIAL SAFETY DATA SHEET

Issue Date: 26-Jan-2009 Revision Date: 14-Oct-2014 Version 1 1. IDENTIFICATION. Foaming Glass Cleaner. 2. HAZARDS IDENTIFICATION

Revision Date 20-May-2015 Version 1 1. PRODUCT AND COMPANY IDENTIFICATION. INFOTRAC (International) (North America)

MATERIAL SAFETY DATA SHEET

Safety Data Sheet. Chemical Product and Company Identification. Hazards Identification. Hazardous Ingredients / Identity Information

15 Hampshire St. Mansfield, MA 02048

2. HAZARDS IDENTIFICATION

TEKNOVA, INC 2290 BERT DR, HOLLISTER, CA , FAX EMERENCY TELEPHONE NUMBER CHEMTREC (800) Page 1 of 6 Rev.

MetriCide Powder Activator Date Prepared: 7/14/2015

: GLADE PLUG-INS SCENTED OIL - OCEAN BLUE

SAFETY DATA SHEET. Great Lakes Orthodontics 200 Cooper Ave Tonawanda, NY CHEMTREC:

Mixture Name Product identifier % Classification (GHS-US)

Safety Data Sheet. Ammonium Sulfate NF. In Case of Emergency Call: CHEMTREC or (24 Hours/Day, 7 Days/Week)

MATERIAL SAFETY DATA SHEET according to the (US) Hazard Communication Standard (29 CFR )

Transcription:

Material Safety Data Sheet VALCYTE(R) Powder for Constitution 1. Product and Company Identification Product name VALCYTE(R) Powder for Constitution Product code 10061366 Use Company information Therapeutic Category: Antiviral Enquiries: HoffmannLa Roche Inc. 340 Kingsland Street USANutley, N.J. 071101199 United States of America Phone 001973/235 50 00 EMail info.sds@roche.com US Emergency phone: (800)8276243 US Chemtrec phone: (800)4249300 2. Hazards identification Emergency Overview Form Color Hazard Overview Potential Health Effects powder white to slightly yellow May cause blood system changes. May cause birth defects based on information on related materials May cause reproductive systems effects based on information on related materials Possible dust explosion hazard based on information on related materials Exposure: Inhalation, Ingestion, Skin contact, Eye contact Target Organs: Hematopoietic/blood system Acute Effects: May cause eye irritation., This material has not been tested as a whole; therefore, the information described below is based on one or more of its ingredients. Chronic Effects: May cause blood system effects. Carcinogenicity: formulation not listed by NTP, IARC or OSHA Additional Health Information Reproduction Toxicity: May cause birth defects based on information on related materials. Since this material may affect reproductive capability and the developing fetus, females and males planning to have a child and pregnant women should exercise caution regarding exposure. Page: 1/5

3. Composition/Information on ingredients It is also advisable for nursing mothers to exercise caution regarding exposure. Ingredients CAS: 175865595 Fumaric acid CAS: 110178 Concentration ~ 46 % ~ 2 % 4. Firstaid measures Eye contact Skin contact Inhalation Ingestion in case of contact with eyes rinse thoroughly with plenty of water and get medical advice remove immediately contaminated clothes, wash affected skin with plenty of water in case of inhalation remove to fresh air and seek medical aid consult physician 5. Firefighting measures Suitable extinguishing media water spray jet, dry powder, foam, carbon dioxide Flash point (liquid) (Not applicable) Specific hazards Protection of firefighters Special method of firefighting consider dust explosion hazard use selfcontained breathing apparatus cool endangered containers with water spray 6. Accidental release measures Personal precautions ensure adequate ventilation Page: 2/5

7. Handling and storage Handling Technical measures Use with adequate ventilation processing in closed systems, if possible superposed by inert gas (e.g. nitrogen) avoid dust formation; consider dust explosion hazard take precautionary measures against electrostatic charging Storage Storage conditions 2 25 C dry and ventilated place 8. Exposure controls/personal protection Engineering Measures see 7. Threshold value (Roche) air IOEL (Internal Occupational Exposure Limit): 5 µg/m3 *1 Personal protective equipment Respiratory protection Hand protection Eye protection Body protection General protective and hygiene measures Respiratory protection is recommended as a precaution to minimze exposure. Effective engineering controls are considered to be the primary means to control worker exposure. Respiratory protection should not substitute for feasible engineering controls. Respiratory protection is recommended for dusty operations. Use of a negative pressure air purifying, half face respirator with a toxic/dust/mist/fume high efficiency filter in the laboratory or a suppliedair full facepiece respirator or suppliedair hood for production operations is recommended. protective gloves tightly fitting safety glasses protective clothing instruction of employees mandatory shower after work recommended *1 9. Physical and chemical properties Color Form white to slightly yellow powder Page: 3/5

10. Stability and reactivity Stability Materials to avoid stable under normal conditions strong oxidizing agents 11. Toxicological information Acute toxicity LD 50 > 2 000 mg/kg (oral, mouse) *1 LD 50 > 1 000 mg/kg (oral, dog) *1 Local effects eye: nonirritant (rabbit) *1 skin: nonirritant (rabbit) *1 skin: slightly irritating (rabbit) *2 eye: moderately irritating (rabbit) *2 Sensitization nonsensitizing (guinea pig) *1 Chronic toxicity NOEL 2 mg/kg/d (oral, rat; 90 days) *1 NOAEL 1 mg/kg/d (oral, mouse; 180 days) *1 NOEL < 0.2 mg/kg/d (oral, dog; 90 days) *1 Mutagenicity mutagenic *1 Note excretion is mainly renal *1 elimination halflife: 5 h *1 after oral administration ester hydrolysis to the active substance Ganciclovir *1 occurs testicular atrophy, renal and hematologic changes *1 *1 *2 FUMARIC ACID 12. Ecological information Inherent biodegradability Ecotoxicity not inherently biodegradable 2 %, 28 days *3 evidence for mediumterm biodegradation in surface waters *3 barely toxic for microorganisms (bacteria, fungi, cyanobacteria in pure culture) NOEC 1000 mg/l *3 barely toxic for planktonic crustaceans (Daphnia magna) EC 50 (48 h) > 1010 mg/l (average measured concentration) NOEC (48 h) 1010 mg/l (average measured concentration) *3 barely toxic for fish (rainbow trout) LC 50 (96 h) > 1020 mg/l (average measured concentration) NOEC (96 h) 1020 mg/l (average measured concentration) *3 barely toxic for fish (bluegill sunfish) LC 50 (96 h) > 1020 mg/l (average measured concentration) NOEC (96 h) 1020 mg/l (average measured concentration) *3 Oncorhynchus kisutch LC 50 (24 weeks) 10 mg/l *2 Daphnia magna EC 50 (48 hours) 212 mg/l *2 Page: 4/5

Mobility barely volatile (waterair) KH = 0.00000026 Pa*m3/mol (vapor pressure/water solubility) *3 *2 *3 FUMARIC ACID Ganciclovir 13. Disposal considerations Waste from residues RCRA waste observe local/national regulations regarding waste disposal incinerate in qualified installation with flue gas scrubbing not regulated under RCRA 14. Transport information Note not classified by transport regulations, proper shipping name nonregulated 15. Regulatory information TSCA Status Reporting Requirements FDA Exemption not on inventory The United States Environmental Protection Agency (USEPA) has not established a Reportable Quantity (RQ) for releases of this material. In New Jersey, report all releases which are likely to endanger the public health, harm the environment or cause a complaint to the NJDEPE Hotline (16092925560) and to local officials. State and local regulations vary and may impose additional reporting requirements. 16. Other information Edition documentation changes from previous version in sections 1 The information in this safety data sheet is based on current scientific knowledge. It should not be taken as expressing or implying any warranty concerning product characteristics. Page: 5/5